Prospective study of Chironex fleckeri and other box jellyfish stings in the "Top End" of Australia's Northern Territory

Medical Journal of Australia

Volumn 183, Issue 11-12, 2005, Pages 631-636

  Currie, Bart J ^a,b   Jacups, Susan P ^a,b  

^a MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ICE; MAGNESIUM; NARCOTIC AGENT; SNAKE VENOM ANTISERUM; VINEGAR;

ADOLESCENT; ADULT; AGED; ARTICLE; AUSTRALIA; CARDIOPULMONARY INSUFFICIENCY; CHILD; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL STUDY; COMMUNITY CARE; CONTROLLED STUDY; DEMOGRAPHY; ENVENOMATION; FATALITY; FEMALE; HEALTH CARE FACILITY; HOSPITAL ADMISSION; HUMAN; JELLYFISH; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PAIN; PROSPECTIVE STUDY; SEASHORE; SEASONAL VARIATION; SKIN EXAMINATION; SNAKE; VICTIM; WEATHER;

EID: 29444437611     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2005.tb00062.x     Document Type: Article

References (27)

1. Williamson JA, Fenner PJ, Burnett JW, Rifkin JK, editors. Venomous and poisonous marine animals - a medical and biological handbook. Sydney: University of New South Wales Press, 1996.
2. Barnes JH. Studies on three venomous cubomedusae. Symp Zool Soc London 1966; 16: 309-332.
3. Carrette T, Alderslade P, Seymour J. Nematocyst ratio and prey in two Australian cubomedusans, Chironex fleckeri and Chiropsalmus sp. Toxicon 2002; 40: 1547-1551.
4. Barnes JH. Chironex fleckeri and Chiropsalmus quadrigatus - morphological distinctions. North Queensland Naturalist 1965; 32: 13-22.
5. Koyama T, Noguchi K, Matsuzaki T, et al. Haemodynamic effects of the crude venom from nematocysts of the box-jellyfish Chiropsalmus quadrigatus (Habu-kurage) in anaesthetized rabbits. Toxicon 2003; 41: 621-631.
6. Currie BJ, McKinnon M, Whelan B, Alderslade P. The Gove chirodropid: a box jellyfish appear ing in the "safe season". Med J Aust 2002; 177: 649.
7. Currie BJ, Wood YK. Identification of Chironex fleckeri envenomation by nematocyst recovery from skin. Med J Aust 1995; 162: 478-480.
8. O'Reilly GM, Isbister GK, Lawrie PM, et al. Prospective study of jellyfish stings from tropical Australia, including the major box jellyfish Chironex fleckeri. Med J Aust 2001; 175: 652-655.
9. Williamson JA, Callanan VI, Hartwick RF. Serious envenomation by the Northern Australian box-jellyfish (Chironex fleckeri). Med J Aust 1980; 1: 13-16.
10. Williamson JA, Le Ray LE, Wohlfahrt M, Fenner PJ. Acute management of serious envenomation by box-jellyfish (Chironex fleckeri). Med J Aust 1984; 141: 851-853.
11. Lumley J, Williamson JA, Fenner PJ, et al. Fatal envenomation by Chironex fleckeri, the north Australian box jellyfish: the continuing search for lethal mechanisms. Med J Aust 1988; 148: 527-534.
12. Hartwick RF. Distribution ecology and behaviour of the early life stages of the box-jellyfish Chironex fleckeri. Hydrobiologia 1991; 216/217: 181-188.
13. Seymour JE, Carrette TJ, Sutherland PA. Do box jellyfish sleep at night? Med J Aust 2004; 181: 707.
14. Macrokanis CJ, Hall NL, Mein JK. Irukandji syndrome in northern Western Australia: an emerging health problem. Med J Aust 2004; 181: 699-702.
15. Little M, Mulcahy RF. A year's experience of Irukandji envenomation in far north Queensland. Med J Aust 1998; 169: 638-641.
16. Fenner PJ, Rodgers D, Williamson J. Box jellyfish antivenom and "Irukandji" stings. Med J Aust 1986; 144: 665-666.
17. Currie BJ. Marine antivenoms. J Toxicol Clin Toxicol 2003; 41: 301-308.
18. Bailey PM, Little M, Jelinek GA, Wilce JA. Jellyfish envenoming syndromes: unknown toxic mechanisms and unproven therapies. Med J Aust 2003; 178: 34-37.
19. Mustafa MR, White E, Hongo K, et al. The mechanism underlying the cardiotoxic effect of the toxin from the jellyfish Chironex fleckeri. Toxicol Appl Pharmacol 1995; 133: 196-206.
20. Ramasamy S, Isbister GK, Seymour JE, Hodgson WC. The in-vivo cardiovascular effects of box jellyfish Chironex fleckeri venom in rats: efficacy of pre-treatment with antivenom, verapamil and magnesium sulphate. Toxicon 2004; 43: 685-690.
21. Endean R, Sizemore DJ. The effectiveness of antivenom in countering the actions of box-jellyfish (Chironex fleckeri) nematocyst toxins in mice. Toxicon 1988; 26: 425-431.
22. Tibballs J, Williams D, Sutherland SK. The effects of antivenom and verapamil on the haemodynamic actions of Chironex fleckeri (box jellyfish) venom. Anaesth Intensive Care 1998; 26: 40-45.
23. Corkeron MA. Magnesium infusion to treat Irukandji syndrome. Med J Aust 2003; 178: 411.
24. Corkeron M, Pereira P, Makrocanis C. Early experience with magnesium administration in Irukandji syndrome. Anaesth Intensive Care 2004; 32: 666-669.
25. Fenner PJ, Williamson JA, Blenkin JA. Successful use of Chironex antivenom by members of the Queensland Ambulance Transport Brigade. Med J Aust 1989; 151: 708-710.
26. Beadnell CE, Rider TA, Williamson JA, Fenner PJ. Management of a major box jellyfish (Chironex fleckeri) sting. Lessons from the first minutes and hours. Med J Aust 1992; 156: 655-658.
27. Maguire EJ. Chironex fleckeri ("sea wasp") sting. Med J Aust 1968; 2: 1137-1138.